SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.53    -0.002 (-0.38%)
Bid:
0.51
Ask:
0.528
Spread: 0.018 (3.529%)
Market Cap: $308.10m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

TR1 Notification

10 Dec 2019 12:47

RNS Number : 3961W
Integrated Diagnostics Holdings PLC
10 December 2019
Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Integrated Diagnostic Holdings Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Intra-group reorganisation

X

3. Details of person subject to the notification obligationiv See Section 9

Name

Actis LLP

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Actis IDH B.V. (outgoing shareholder)

City and country of registered office (if applicable)

Amsterdam, The Netherlands

Name

Actis IDH Limited (incoming shareholder)

City and country of registered office (if applicable)

St Peter Port, Guernsey

5. Date on which the threshold was crossed or reachedvi:

06/12/2019

6. Date on which issuer notified (DD/MM/YYYY):

06/12/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

21.00%

0.00%

21.00%

150,000,000

Position of previous notification (if

applicable)

21.00%

0.00%

21.00%

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ISIN: JE00BV9H9G76

31,500,000

0

21.00%

0.00%

SUBTOTAL 8. A

31,500,000

21.00%

Β 

Β 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8.B.2

Β 

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 LP)

8.32%

0

8.32%

Actis Global 4 LP

8.32%

0

8.32%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 A LP)

2.67%

0

2.67%

Actis Global 4 A LP

2.67%

0

2.67%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 C LP)

0.83%

0

0.83%

Actis Global 4 C LP

0.83%

0

0.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 LP)

4.54%

0

4.54%

Actis Africa 4 LP

4.54%

0

4.54%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 A LP)

3.83%

0

3.83%

Actis Africa 4 A LP

3.83%

0

3.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis Guernsey GP Limited (as general partner of Actis 4 Co-Investment Scheme LP)

0.81%

0

0.81%

Actis 4 Co-Investment Scheme LP

0.81%

0

0.81%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

As announced on 31 December 2018 by Integrated Diagnostics Holdings plc, Actis IDH B.V., a holding company ultimately controlled by Actis GP LLP in its capacity as the General Partner of each of the limited partnerships comprising Actis Global 4 and Actis Africa 4, and which holds a 21% shareholding in the Integrated Diagnostics Holdings plc, has transferred its entire shareholding in Integrated Diagnostics Holdings plc to its affiliate, Actis IDH Limited, as result of an intra-group reorganisation. Actis IDH Limited is also ultimately controlled by Actis GP LLP.

Β 

Place of completion

Jersey

Date of completion

06/12/2019

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
HOLBDBDDDSBBGCG
Date   Source Headline
9th Apr 201812:02 pmRNSPrice Monitoring Extension
3rd Apr 20184:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
28th Mar 201811:54 amRNSHolding(s) in Company
21st Mar 20187:00 amRNSFinal Results
26th Feb 20189:49 amRNSAward from the College of American Pathologists
1st Dec 20177:52 amRNSInvestment in Nigeria's Echo-Scan
22nd Nov 20177:00 amRNSTrading Update
22nd Sep 20173:29 pmRNSHolding(s) in Company
22nd Aug 20177:00 amRNSHalf-year Report
16th Jun 20174:42 pmRNSSecond Price Monitoring Extn
16th Jun 20174:35 pmRNSPrice Monitoring Extension
23rd May 20177:00 amRNSTrading Statement
22nd May 20174:22 pmRNSResult of AGM
27th Apr 20171:12 pmRNSAnnual Financial Report
22nd Mar 20177:00 amRNSFinal Results
10th Mar 20172:55 pmRNSHolding(s) in Company
28th Feb 20174:40 pmRNSSecond Price Monitoring Extn
28th Feb 20174:35 pmRNSPrice Monitoring Extension
23rd Nov 20167:00 amRNSTrading Statement
3rd Nov 20162:02 pmRNSVice President of Finance and Strategy Appointment
23rd Aug 20167:00 amRNSHalf-year Report
6th Jul 201612:07 pmRNSSecond Price Monitoring Extn
6th Jul 201612:02 pmRNSPrice Monitoring Extension
27th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20164:35 pmRNSPrice Monitoring Extension
11th May 20167:00 amRNSUpdate on Q1 2016 Results
9th May 20164:03 pmRNSResult of AGM
26th Apr 20164:40 pmRNSSecond Price Monitoring Extn
26th Apr 20164:35 pmRNSPrice Monitoring Extension
18th Apr 20163:23 pmRNSAnnual Financial Report
29th Mar 20167:00 amRNSFinal Results
16th Mar 20164:40 pmRNSSecond Price Monitoring Extn
16th Mar 20164:35 pmRNSPrice Monitoring Extension
30th Dec 20154:40 pmRNSSecond Price Monitoring Extn
30th Dec 20154:35 pmRNSPrice Monitoring Extension
7th Dec 20153:59 pmRNSHolding(s) in Company
23rd Nov 20157:00 amRNSTrading Statement
20th Oct 20154:40 pmRNSSecond Price Monitoring Extn
20th Oct 20154:35 pmRNSPrice Monitoring Extension
5th Oct 20154:40 pmRNSSecond Price Monitoring Extn
5th Oct 20154:35 pmRNSPrice Monitoring Extension
1st Oct 20154:40 pmRNSSecond Price Monitoring Extn
1st Oct 20154:35 pmRNSPrice Monitoring Extension
14th Sep 20154:35 pmRNSPrice Monitoring Extension
28th Aug 20154:40 pmRNSSecond Price Monitoring Extn
28th Aug 20154:35 pmRNSPrice Monitoring Extension
24th Aug 20154:40 pmRNSSecond Price Monitoring Extn
24th Aug 20154:35 pmRNSPrice Monitoring Extension
24th Aug 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.